Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic obstructive pulmonary disease (COPD)
Pharma
AZ's Fasenra flunks COPD trial as Saphnelo makes grade in lupus
After another swing and a miss for AstraZeneca's Fasenra in COPD, the company will prioritize other candidates for the indication.
Kevin Dunleavy
Sep 17, 2025 11:47am
GSK-Hengrui, Takeda, Celltrion—Fierce Pharma Asia
Aug 1, 2025 9:00am
Respiratory royalty rally around rural COPD education drive
Jul 9, 2025 8:05am
FDA misses target date for GSK's Nucala in COPD
May 8, 2025 1:39pm
Sanofi aims to grow Beyfortus after blockbuster sales year
Jan 30, 2025 11:45am
Verona's new COPD drug Ohtuvayre racked up sales of $42M in 2024
Jan 7, 2025 1:27pm
